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Growth factors and mechanical cues synergistically affect cellular functions,
triggering a variety of signaling pathways. The molecular levels of such
cooperative interactions are not fully understood. Due to its role in
osteogenesis, the growth factor bone morphogenetic protein 2 (BMP-2) is of
tremendous interest for bone regenerative medicine, osteoporosis
therapeutics, and beyond. Here, contribution of BMP-2 signaling and
extracellular mechanical cues to the osteogenic commitment of C2C12 cells is
investigated. It is revealed that these two distinct pathways are integrated at
the transcriptional level to provide multifactorial control of cell differentiation.
The activation of osteogenic genes requires the cooperation of BMP-2
pathway-associated Smad1/5/8 heteromeric complexes and
mechanosensitive YAP/TAZ translocation. It is further demonstrated that the
Smad complexes remain bound onto and active on target genes, even after
BMP-2 removal, suggesting that they act as a “molecular memory unit.” Thus,
synergistic stimulation with BMP-2 and mechanical cues drives osteogenic
differentiation in a programmable fashion.
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Chemical and physical cues act upon cells to
mediate a wide range of behaviors, includ-
ing growth, differentiation, and survival.[1,2]
Mechanotransduction enables cells to sense
and respond to physical cues like extra-
cellular matrix (ECM) viscoelasticity, lig-
and density, and topography.[3–6] These
mechanical cues are translated into bio-
chemical signals, ultimately activating nu-
clear transcription factors that control gene
transcription for downstream molecular
outputs and phenotypic maintenance or
diversity.[7,8] Separately, biochemical cues
provided by soluble growth factors regu-
late a variety of cellular processes, includ-
ing the induction of cell fate during devel-
opment. Growth factors initiate numerous
signaling cascades by binding to and ac-
tivating complementary receptors.[9] While
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the activity of several growth factors has been shown to be de-
pendent on mechanical cues,[10] the crosstalk between mechan-
otransduction pathways and growth factor signaling is not yet
well-understood.
Bone morphogenetic protein 2 (BMP-2) belongs to the trans-
forming growth factor 𝛽 (TGF-𝛽) superfamily. Beyond its canoni-
cal role in initiating the differentiation of osteoprogenitor cells
into mature osteoblasts, it also is capable of stimulating the
transdifferentiation of non-osteogenic cells into osteoblasts.[11]
The BMP-2 signaling cascade is activated via interactions be-
tween BMP-2 and its heteromeric transmembrane receptor com-
posed of types I and II serine/threonine kinase receptors. This
activation induces recruitment and phosphorylation of Smad
family signal transducing proteins Smad1/5/8. Heteromeric
complexes are subsequently formed between phosphorylated
Smad1/5/8 and the common mediator Smad4. These com-
plexes then accumulate in the nucleus[12] to regulate target gene
transcription.[13,14]
Several previous studies have noted that the efficiency of BMP-
2-induced osteogenic differentiation is highly dependent on cell
shape, cytoskeletal tension, cell–ligand interactions, and matrix
stiffness.[15–18] In other words, BMP-2 signaling and mechan-
otransduction pathways appear tightly interconnected.[14,19] A
biological example of crosstalk related to cell shape regulation
exists in the soft articular joints or soft bone marrow, where
chondrogenic progenitor or adipogenic precursor cells, respec-
tively, exhibit a spherical phenotype and resist being forced into
an osteogenic fate when exposed to local BMP gradients.[15]
Here, we examine how mechanical cues, that is, matrix stiff-
ness and cytoskeletal tension, affect biochemical signaling in a
key step of the BMP-2-induced Smad1/5/8 signaling cascade.
We then identify which step of osteogenesis towards an osteoge-
nesis lineage is suppressed when cells lack cytoskeletal tension.
Hippo pathway effectors YAP (Yes-associated protein) and TAZ
(transcriptional coactivator with PDZ-binding motif, also known
as WWTR1), which are well-known mechanosensitive mediators
of mechanical cues,[8] are highlighted as key transcriptional
regulators that coactivate osteogenic genes with Smad1/4/5/8
heteromeric complexes. Finally, we provide evidence that Smad
signaling activity persists even after the removal of BMP-2 in
a process that serves as a “molecular memory unit” for BMP-2
signaling. Ultimately, programmable BMP-2 stimulation and
mechanical cues were synergistically utilized to induce and
enhance osteogenic differentiation.
2. Results
2.1. Cytoskeletal Tension Mediates BMP-2-Induced Osteogenic
Differentiation
To investigate the role of mechanotransduction in BMP-2 sig-
naling, we monitored BMP-2-induced osteogenic differentiation
of C2C12 mouse myoblasts on polyethylene glycol (PEG) hydro-
gels, which were functionalized with RGD peptides to promote
cell adhesion. C2C12 cells are myoblasts that are able to trans-
differentiate into osteoblasts upon stimulation with BMPs and
represent an established in vitro model system to study BMP-
2 signaling.[20,21] C2C12s are a compelling cell line for untan-
gling the independent contributions of both substrate stiffness
andBMP-2 signaling pathways precisely because their osteogenic
differentiation is dependent upon both, rather than just one (as
is the case with mesenchymal stem cells (MSCs)).[22] In C2C12s,
osteogenic differentiation is only observed when cells are treated
with BMP-2 and are exposed to high levels of substrate stiffness.
By altering these two variables independently, we can better un-
derstand the dynamic role each modality plays in the onset of os-
teogenesis. In MSCs, the activation of osteogenetic genes can be
provoked by either BMP-2 signaling or substrate stiffness. Thus,
perturbing one pathway will not result in a relative loss of os-
teogenesis, preventing us from understanding the interplay be-
tween the twomodalities. Therefore, the C2C12model is a power-
ful tool for investigating the synergistic role of matrix mechanics
and BMP-2 signaling in osteogenic differentiation.
Hydrogel stiffness was tuned by varying the concentration of
PEG diacrylate, modulating the number of backbone polymers
within the hydrogel network. The elastic moduli of the hydrogels,
measured by rheometry, ranged from 0.8 to 77 kPa (Figure 1a),
within the range of physiological elasticity of natural tissues.[22]
PEG hydrogels prevent the nonspecific adsorption of proteins,[23]
allowing cells to directly sense matrix stiffness via integrin–RGD
ligand interactions.[24,25]
Osteogenic differentiation of C2C12 cells on the hydrogels was
evaluated by quantifying alkaline phosphatase (ALP) activity, as
well as staining for ALP expression (Figure 1b–d). Following ad-
dition of BMP-2 to the culture media, cells on the stiffest (77 kPa)
hydrogels expressed the highest ALP activity, comparable to cells
on tissue culture polystyrene (TCPS). ALP activity decreased as
stiffness decreased, with the lowest expression observed on the
softest (0.8 kPa) hydrogels. These results confirm previous re-
ports that BMP-2-induced osteogenic differentiation in C2C12s
and MSCs is mediated by matrix stiffness.[17,18]
To gain more insight into the potential role of mechanotrans-
duction in BMP-2 signaling, C2C12 cell adhesion on hydrogels
with varying stiffness was investigated. As anticipated from pre-
vious studies,[21,26] a higher amount of cells adhered on stiff hy-
drogels than on soft hydrogels (Figure 1e,f). Cell spread area was
also greater on stiffer hydrogels (Figure 1g,h). BMP-2 has been
reported to increase cytoskeletal tension and alter spread area;[27]
however, we did not observe significant differences in spread area
as a result of BMP-2 treatment, suggesting that substrate stiffness
overrides the effect of the growth factor. F-actin staining showed
that stress fibers were more pronounced and parallel to the cell’s
major axis on 35 and 77 kPa hydrogels, while cells on 8 kPa hydro-
gels were smaller and displayed decreased stress fiber bundles.
On 0.8 kPa hydrogels, in which cells were the smallest, stress
fiber formation was greatly hindered (Figure 1g). As stress fiber
formation contributes to the generation of intrinsic cytoskeletal
tension and is thus a key step in mechanotransduction, we can
conclude that mechanotransductionmay be linked to BMP-2 sig-
naling via cytoskeletal tension.
To confirm this, pharmacological agents that interfere with cel-
lular tension and actin dynamics were utilized in cells on TCPS.
As myosin is one of the key components regulating cytoskele-
tal tension, we employed blebbistatin (Blebb), an inhibitor of
myosin II, and calyculin A (Calyc), which inhibits myosin light-
chain phosphatase from dephosphorylating myosin, resulting in
increased myosin II activation. Perturbation of myosin II activity
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Figure 1. BMP-2-induced osteogenic differentiation of C2C12 cells. a) Average elastic modulus of PEG hydrogels (error bars are SD, n = 3, two technical
replicates, Welch’s t-test). b) Quantitative assay of ALP activity in C2C12 cells cultured in different conditions for 7 days (n= 2–3, two technical replicates,
one-way ANOVA followed by post hoc Tukey’s multiple comparisons test). c) Representative images of ALP staining for C2C12 cells on PEG hydrogels of
different stiffness for 5 days. d) Representative images of ALP staining for C2C12 cells on TCPS with or without BMP-2 and inhibitor treatment for 7 days.
e) Representative images of F-actin staining of C2C12 cells cultured in different conditions for 24 h. f) The number of attached C2C12 cells related to
cells on TCPS without BMP-2 treatment (n = 5, two technical replicates, Welch’s t-test). g) Representative high-magnification images of F-actin staining
of C2C12 cells cultured in different conditions for 24 h. h) Spread area of C2C12 cells cultured in different conditions for 24 h (n = 50, two technical
replicates, Welch’s t-test). TCPS: cells were cultured on TCPS; Blebb: cells were treated with blebbistatin; Calyc: cells were treated with calyculin A; X kPa:
cells were cultured on hydrogels with stiffness X kPa.
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by Blebb dramatically decreased stress fiber formation and cell
spread area (Figure 1g,h), as well as ALP activity (Figure 1b,d).
In contrast, increased myosin II activation resulted in enhanced
organization of stress fibers and cell spread area, as well as ALP
activity. Surprisingly, stimulation by Calyc alone in the absence of
BMP-2 was sufficient to induce an increase in ALP expression in
C2C12 cells. This is likely due to the largely enhanced cytoskele-
tal tension. Of all culture conditions, cells treated with both Ca-
lyc and BMP-2 exhibited the highest ALP activity. Together, the
results of the inhibitor experiments indicate that cytoskeletal ten-
sion is the mediator of BMP-2-induced osteogenic differentia-
tion of C2C12 cells. This finding further raises the question of
whether cytoskeletal tension is critical for either the initiation or
the subsequent propagation of the BMP-2 signaling cascade.
Elasticity directs cellular mechanotransduction through a set
of extra- and intracellular signaling pathways involving inte-
grins, focal adhesion kinase (FAK), Rho/ROCK, lamin-A/C, and
YAP/TAZ, to name a few.[28,29] As mechanosensitive signaling
pathways have been heavily investigated in recent years, we
chose here to focus specifically on the relationship between
mechanosensitive signaling and BMP-2 signaling.
2.2. BMP-2 Signaling Initiation Is Relatively Independent of
Mechanical Cues
Fusion and differentiation of C2C12 cells into multinucleated
myotubes was monitored by staining for the marker myosin
heavy chain (MHC).[11] In the presence of BMP-2, C2C12 cells
failed to form MHC positive myotubes on TCPS or hydrogels,
with or without pharmacological agent treatment (Figure S1,
Supporting Information). Conversely, in the absence of BMP-2,
MHC-positive myotubes were clearly observed when cells were
confluent in all experimental conditions except Calyc treatment.
This indicates that BMP-2 signaling is initiated (as proven by in-
hibition of myogenesis), but later blocked (as proven by lack of
osteogenesis), on soft hydrogels where ALP activity is at a min-
imum. To determine how mechanical cues affect BMP-2 signal-
ing, we assayed the BMP-2-induced Smad signaling cascade in a
stepwise fashion.
BMP-2 binds to and stabilizes membrane complexes con-
sisting of types I and type II receptors. The type II receptor
then phosphorylates and activates the type I receptor, recruiting
and phosphorylating Smad1/5/8 at its C-terminal SSXS-motif
to initiate the canonical Smad cascade.[14] Thus, phosphorylated
Smad1/5/8 (pSmad1/5/8) was used as a reporter for BMP-2
activity.[30,31] To examine its phosphorylation state, cells were first
seeded on TCPS or hydrogels with or without Blebb or Calyc pre-
treatment, then stimulated with BMP-2 for 60 min. pSmad1/5/8
levels were determined by Western blot and normalized to
𝛽-actin expression (Figure 2a,b). In the absence of BMP-2 stim-
ulation, Smad1/5/8 phosphorylation was not observed in any
experimental conditions. In BMP-2 stimulated cells, the use
of soft hydrogels or Blebb treatment resulted in a 20–25% de-
crease in Smad1/5/8 phosphorylation compared to TCPS or stiff
hydrogels.
Downstream Smad signaling processes, which involve nuclear
translocation of Smad complexes and further binding to target
genes, were investigated by immunostaining of the Smad1/5/8
complex (Figure 2c,e) and luciferase reporter assay (Figure 2d),
respectively. pSmad1/5/8 was highly enriched only in the nuclei
of cells stimulated with BMP-2, with Blebb treatment and the
lowest hydrogel stiffness (0.8 kPa) inducing a slight decrease in
nuclear localization. C2C12 cells stably transfected with a BMP-
responsive luciferase reporter (BRE-Luc) containing Smad bind-
ing elements derived from the Id1 promoter[32] were treated with
BMP-2. BRE-Luc activity was fivefold to 10-fold higher in cells
stimulated with BMP-2 compared to unstimulated cells. Consis-
tent with Smad1/5/8 phosphorylation and Smad complex nu-
clear translocation, Blebb treatment or 0.8 kPa hydrogel stiffness
resulted in a 30% decrease in BRE-Luc activity.
It has been reported that cell shape regulates Smad signal-
ing via RhoA/ROCK activity and downstream cytoskeletal ten-
sion generation. Smad signaling was decreased, but not totally
blocked, when cell spreading was limited.[15] Furthermore, cell
spreading on matrix-bound BMP-2 has been shown to not affect
Smad signaling; ROCK-dependent cytoskeletal tension is not di-
rectly required for the Smad activation.[21] On soft substrates, sol-
uble BMP-2 has been shown to decrease Smad activity to a certain
degree. In our system, we also found that decreased cytoskeletal
tension resulting fromBlebb treatment or a soft substrate slightly
decreased Smad signaling in cells stimulated with BMP-2. How-
ever, Smad signaling in low tension, BMP-2 stimulated cells was
much higher than in unstimulated cells of all conditions. Thus,
the initiation of the BMP-2 signaling cascade via Smad signaling
is relatively independent of mechanical cues.
2.3. Osteogenic Gene Expression Is Regulated
by Mechanical Cues
As the activation of Smad signaling was found to be independent
of mechanical cues, osteogenic gene expression was analyzed via
quantitative real-time reverse transcriptase polymerase chain re-
action (qRT-PCR). Three marker genes related to early (Runt-
related transcription factor 2; RUNX2), intermediate (ALP), and
late (osteopontin;OPN) stages of osteogenic differentiation were
assayed. All three markers were significantly upregulated in a
time-dependent fashion in C2C12 cells grown on TCPS and
stiff 35 and 77 kPa hydrogels in the presence of BMP-2 after
7 days (Figure 2f). The most dramatic upregulation of osteogenic
markers was observed in cells cotreated with BMP-2 and Ca-
lyc. Furthermore, Calyc treatment resulted in upregulation of
these markers even in the absence of BMP-2. In contrast, BMP-
2-treated cells in combination with Blebb or cultured on the soft-
est 0.8 kPa hydrogels displayed a reduction in osteogenic marker
expression.
These patterns of osteogenic gene expression are consistent
with the ALP activity assay and staining results described above.
This observation suggests that osteogenic gene activation is me-
diated by cytoskeletal tension and dictated by mechanotransduc-
tion pathways. Thus, on soft matrices, the BMP-2 signaling path-
way driving osteogenic differentiation is blocked before gene ex-
pression is activated, although the Smad complex successfully
binds to target genes (Figure 2d). Therefore, other transcription
factors or transcriptional regulators may be required to coactivate
osteogenic genes and promote subsequent cell fate specification.
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Figure 2. Activation of BMP-2-induced Smad signaling. a) Representative Western blots for pSmad1/5/8 and the housekeeper protein 𝛽-actin of C2C12
cells that were stimulated for 60 min in different conditions before lysis. b) Quantification of Smad1/5/8 phosphorylation based on Western blot images;
n = 1–2, two technical replicates. c) Nuclear-to-cytoplasmic ratios of pSmad1/5/8 for C2C12 cells cultured in different conditions for 3 h followed by
BMP-2 treatment for 1 h. Quantification was based on immunofluorescence images; n = 15, two technical replicates. d) Luciferase activity of C2C12
BRE-Luc cells cultured in different conditions for 24 h; n = 2, three technical replicates. e) Representative immunofluorescence images of C2C12 cells
stained with DAPI (blue), Alexa Fluor 488 phalloidin (green), and anti-pSmad1/5/8 (red) after culturing in different conditions for 3 h followed by BMP-
2 treatment for 1 h. High-magnification images of anti-pSmad1/5/8 are available in Figure S2, Supporting Information. f) Heat map of the relative
expression levels (y) of the genes related to the early (RUNX2), intermediate (ALP), and late (OPN) periods of osteogenesis in C2C12 cells cultured in
different conditions. Data are analyzed by one-way ANOVA followed by post hoc Tukey’s multiple comparisons test for all panels.
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2.4. YAP/TAZ Are Regulated by Cytoskeletal Tension
A wide range of transcription factors and transcriptional regu-
lators play a role in mechanosensitive gene expression. Specif-
ically, YAP and TAZ have been shown to be sensitive to
mechanical cues via regulation of the Ras-related GTPase
RAP2[33] and the ARID1A-containing SWI/SNF complex.[34]
In addition, YAP/TAZ are well-known for mediating cellular
mechanoresponses.[35]
Thus, we investigated the correlation between endogenous
YAP/TAZ subcellular localization and the presence of cytoskeletal
tension in the presence or absence of BMP-2 stimulation (Figures
S3 and S4, Supporting Information). To this end, immunostain-
ing of both YAP and TAZ was performed in C2C12 cells cultured
on surfaces with different stiffness or treated with pharmacolog-
ical inhibitors. YAP and TAZ both localized to the nucleus on
rigid TCPS and stiffer 35 and 77 kPa matrices. On softer 0.8 and
8 kPa matrices, YAP and TAZ became predominantly cytoplas-
mic. Similarly, both YAP and TAZ were predominantly cytoplas-
micwhen cytoskeletal tensionwas decreased via Blebb treatment.
Calyc treatment did not alter YAP/TAZ localization for cells on
TCPS, while BMP-2 stimulation did not alter YAP/TAZ localiza-
tion in any conditions.
Next, we investigated whether cell spread area regulates BMP-
2 signaling and YAP/TAZ localization. Micropatterned “islands”
of defined size generated on an antifouling PEG coating were uti-
lized to induce changes in cell spread area based on the available
adhesive area in the presence of BMP-2 (Figure S5, Supporting
Information). On these micropatterns, nuclear translocation of
Smad complexes was not affected by cell size. In contrast, YAP
exhibited strong nuclear localization on large islands and weak
nuclear localization on small islands. Similarly, osteogenic differ-
entiation, asmeasured by osterix expression and localization, was
enhanced on large islands. These results on single-cell micropat-
terns rule out the effects of cell–cell contacts on BMP-2 signaling
pathways.[8] YAP/TAZ localization in response to cell spreading
and cytoskeletal tension support the notion that they are potential
mediators of BMP-2 signaling during osteogenic differentiation.
2.5. YAP/TAZ Regulate BMP-2 Signaling
YAP/TAZ subcellular localization patterns merely indicate that
YAP/TAZ are molecular “readers” of cytoskeletal tension. To
prove that YAP/TAZ are relevant in mediating BMP-2 signaling,
transient siRNA-induced knockdowns of YAP, TAZ, or both YAP
and TAZ in C2C12 cells were performed and verified by Western
blot (Figure 3a). Importantly, Smad signaling was not affected
by YAP/TAZ knockdown as measured by luciferase reporter as-
say (Figure 3b). Individual YAP or TAZ knockdown resulted in a
reduction of BMP-2-induced ALP activity by nearly 50% within
1 day of siRNA treatment, and simultaneous knockdown of both
YAP and TAZ resulted in an even stronger reduction in ALP ac-
tivity (Figure 3c,i). After 3 days, ALP activity increased in all sam-
ples, consistent with transient recovery of YAP/TAZ. While indi-
vidual YAP and TAZ knockdown samples returned to control lev-
els, dual YAP/TAZ knockdown samples still exhibited statistically
significant reductions in ALP activity after 3 days (Figure 3d,i).
We also examined YAP and TAZ overexpression in C2C12 cells
via Flag-tagged plasmid transfection, both individually and in
combination (Figure 3e). Plasmid-induced YAP/TAZ overexpres-
sion did not affect Smad signaling (Figure 3f). Overexpression
of YAP, TAZ, and YAP/TAZ in combination for 1 or 3 days re-
sulted in significantly higher levels of ALP activity than in control
groups (Figure 3g,h,j). TAZ overexpression resulted in higher lev-
els of ALP activity than YAP expression, potentially due to the fact
that TAZ is negatively regulated by YAP expression but not vice
versa,[36] although we did not observe a decrease of TAZ levels
during YAP overexpression by Western blot. We also did not ob-
serve this phenomenon in the YAP knockdown experiments, pos-
sibly because the siRNA-induced knockdown we employed was
transient as opposed to the more permanent short hairpin RNA
(shRNA) or CRISPR-Cas9 systems utilized in the literature.[36]
As YAP/TAZ are involved in numerous signaling pathways in
cells,[37] permanent perturbation may cause undesired cell re-
sponses including apoptotic cell death.[38]
Overexpression of both YAP and TAZ not only resulted in
enhanced osteogenic differentiation on TCPS, but also stimu-
lated osteogenic differentiation on soft 0.8 kPa matrices in the
presence of BMP-2, as measured by osterix nuclear localization
(Figure 3k). The EGFP-YAP plasmid and the TAZ plasmid were
mixed together prior to lipids preparation for transfection. Nu-
clear osterix localization (red) was greatly enhanced in efficiently
transfected cells (green), although increased YAP and TAZ
expression did not enhance nuclear accumulation (as measured
by nuclear-cytoplasmic ratio) of YAP/TAZ (Figure S6, Supporting
Information) as observed via immunostaining of total TAZ (ma-
genta) and overexpressed YAP (green). In comparison, nuclear
osterix localization was not observed in BMP-2-treated cells
without plasmid expression. Thus, YAP/TAZ overexpression
in the presence of BMP-2 is sufficient for C2C12 osteogenesis,
even when cytoskeletal tension is limited due to soft substrate
elasticity.
The spread area and stress fiber assembly of TCPS-adherent
cells were also monitored when the expression of both YAP and
TAZ was downregulated or upregulated. No obvious differences
were detected (Figure S7, Supporting Information). Thus, cy-
toskeleton tension is not altered during siRNA or plasmid treat-
ment. Together, this indicates that YAP and TAZ play amajor role
in BMP-2-induced osteogenesis by serving as mechanosensitive
mediators of BMP-2 signaling.
2.6. Smad Complexes and YAP/TAZ Synergize to Activate
Gene Expression
To explore the interplay between Smad complexes and YAP/TAZ
during mechanosensitive gene activation, C2C12 cells were
treated with BMP-2 and Blebb, followed by whole transcriptome
shotgun sequencing (RNA-Seq) (Data 1, Supporting Informa-
tion). Principal component analysis (PCA) of 5813 differentially
expressed genes (DEGs) inherent to specific treatment com-
binations (q value < 0.05) and hierarchical clustering analysis
identified transcriptional signatures sufficient to differenti-
ate cell populations as a function of treatment (Figure S8,
Supporting Information).
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A total of 1536 genes were found to be significantly upregu-
lated in response to BMP-2 (Data 2, Supporting Information). Im-
portantly, half of these BMP-2 responsive genes (867 genes) were
antagonized by Blebb, as revealed by unsupervised hierarchical
clustering analysis (see green cluster, Figure 4a), suggesting that
this cluster of BMP-2 responsive genes is mechanosensitive.
Similarly, a subset of our BMP-2 upregulated genes, which we
characterized as bona fide Smad1/4/5 targets based on previous
ChIP-seq data[39] (Data 3, Supporting Information), was signif-
icantly downregulated when BMP-2 was coupled with Blebb
(70% of these genes were antagonized by Blebb), indicating that
the majority of Smad1/4/5 targets are also mechanosensitive
(Figure 4b,c).
Gene set enrichment analysis (GSEA) of BMP-2 genes re-
vealed an enrichment of YAP/TAZ regulated genes (Cordenonsi
signature, Figure 4d), suggesting a BMP-2-dependent regula-
tion of YAP/TAZ targets. Indeed, canonical YAP/TAZ targets
were upregulated in C2C12 cells by BMP-2 and antagonized by
Blebb (Figure 4e). Interestingly, 26 of our BMP-2-upregulated
Smad1/4/5 targets have also been previously identified as targets
of YAP,[40] although in that study, BMP-2 was not used to stim-
ulate cells, suggesting that other Smad targets may also be YAP
targets (Data 4, Supporting Information). BMP-2-induced upreg-
ulation of over 65% of these YAP target genes was decreased
in response to Blebb treatment (Figure 4f), further strengthen-
ing the finding that BMP-2-induced gene expression is highly
mechanosensitive.
These results suggest that 1) Smad complexes are capable of
activating certain genes in the absence of mechanical stimula-
tion, and 2) Smad complexes coactivate other genes in a con-
certed manner along with YAP/TAZ. The genes identified in (1)
likely contribute to the inhibition of myotube formation, while
those in (2) play a greater role in initiating osteogenic differentia-
tion of C2C12 cells. In addition, osteogenic differentiation likely
also includes other YAP/TAZ-binding transcription factors. In-
deed, the genes Id1, Id2, Id3, and Id4, all of which are DEGs
upregulated by BMP-2, were not affected by Blebb treatment
(Figure S9, Supporting Information). These genes encode DNA-
binding protein inhibitors that have been shown to bind to and
deactivate MyoD and its cofactors, resulting in an inhibition of
myogenesis.[41] Together, these results indicate that Smad sig-
naling can occur both independent of and in conjunction with
mechanical stimulation.
2.7. Nuclear Accumulation of Smad Complexes Maintains BMP-2
Signaling after BMP-2 Withdrawal but Additional Mechanical
Stimulation Is Required for Osteogenesis
Data presented, thus, support the hypothesis that mechani-
cal cues mediate BMP-2 signaling, as osteogenic differentia-
tion of C2C12 cells requires both Smad complex activation and
YAP/TAZ localization. Next, we wanted to determine whether we
could activate these two signaling pathways independently. We
generated an antifouling polymer coating on TCPS based on a
biomimetic amphiphilic block copolymer (Figure 5a),[42] which
prevents ECM protein adsorption and cell adhesion,[43] limiting
external mechanical cues and cytoskeletal tension. C2C12 cells
were initially stimulated with BMP-2 on antifouling TCPS (Anti)
and then transferred onto adhesive TCPS (untreated) without fur-
ther BMP-2 stimulation (Figure 5b). Cell adhesion was not ob-
served on antifouling TCPS, but cells became well-spread after
transfer onto adhesive TCPS (Figure S10, Supporting Informa-
tion). It is worth emphasizing that nonadherent cells were trans-
ferred via simple pipetting, allowing us to avoid trypsinization
or other confounding factors present during passaging. There-
fore, in this setup, Smad signaling can be activated first via BMP-
2 stimulation, followed by subsequent and separate mechanical
stimulation and cytoskeletal tension induced by adhesive TCPS.
To eliminate the effects of proliferation, cells were pretreated
with mitomycin C when cultured on adhesive TCPS for more
than 1 day. Luciferase reporter assays indicated that C2C12 BRE-
Luc cells on antifouling TCPS exhibited slightly lower luciferase
activity compared to cells on adhesive TCPS after BMP-2 stimu-
lation for 1 day (pretreatment), but exhibited eight times higher
activity compared to cells that did not receive BMP-2 treatment
(Figure 5c). Interestingly, luciferase activity can be maintained in
pretreated cells for at least 3 days on both antifouling and adhe-
sive TCPS after the removal of BMP-2 (Figure 5d). This means
that BMP-2-induced Smad complexes continuously bind and ac-
tivate target genes once initiation has occurred. Immunostaining
also confirmed that nuclear pSmad1/5/8 localization was persis-
tent in pretreated cells once they had been transferred onto ad-
hesive TCPS in the absence of BMP-2 (Figure S11, Supporting
Information).
Nuclear YAP accumulation did not occur in pretreated cells
subsequently transferred onto adhesive TCPS and fixed after
20 min, indicating that the pretreatment phase did not induce
YAP/TAZ translocation. Once cells were sufficiently spread with
well-organized actin stress fibers, nuclear YAP accumulation was
observed (Figure 5e). Pretreated cells did exhibit high ALP activ-
ity after both 1 and 3 days post-transfer onto adhesive TCPS, but
not when kept on antifouling TCPS (Figure 5f,g). Osteogenic dif-
ferentiation was also monitored via osterix nuclear localization.
In line with nuclear accumulation of YAP, only well-spread, pre-
treated cells exhibited high osterix localization (Figure S12, Sup-
porting Information).
To determine the effect of the duration of BMP-2 pulse stim-
ulation on Smad signaling, we provided BMP-2 stimulation to
C2C12 and C2C12 BRE-Luc cells at various time points between
30 min and 3 days before transferring them onto adhesive TCPS.
Figure 3. Upregulation and downregulation of YAP/TAZ to mediate BMP-2 signaling. a) Representative Western blots of YAP and TAZ expression in
lysates collected 1 or 3 days post-siRNA treatment. b) Luciferase activity in C2C12 BRE-Luc cells treated with siRNAs; n = 3. c,d) Quantification of ALP
activity for C2C12 cells cultured c) 1 day or d) 3 days post-siRNA treatment; n = 3. e) Representative Western blots of total YAP/TAZ and Flag-tagged
YAP/TAZ expression in lysates collected 1 day post-transfection. f) Luciferase activity in C2C12 BRE-Luc cells transfected with Flag-tagged YAP/TAZ; n =
3. g,h) Quantitative assay of ALP activity for C2C12 cells cultured g) 1 day or h) 3 days post-transfection; n= 2, two technical replicates. i,j) Representative
images of ALP staining in BMP-2-stimulated C2C12 cells cultured 1 or 3 days i) post-siRNA or j) Flag-tagged YAP/TAZ transfection. k) Representative
immunofluorescence images of C2C12 cells cultured on soft 0.8 kPa hydrogels in the presence of BMP-2 2 days after transfection with pEGFP-C3-hYAP1
and pEF-TAZ-N-Flag plasmid. Blue: DAPI; magenta: anti-TAZ; green: plasmid-generated YAP; red: anti-osterix. Data are analyzed by one-way ANOVA
followed by post hoc Tukey’s multiple comparisons test, p-values referenced to NC group.
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Figure 4. Cooperative gene activation by BMP-2 stimulation and mechanical cues. a) Hierarchical clustering analysis of genes upregulated by BMP-2.
b) Hierarchical clustering analysis of the Smad1/4/5 targets identified from genes in (a). c) Pie chart of the Smad1/4/5 targets in (b) based on the
data of Blebb&BMP-2 versus BMP2. d) GSEA of BMP-2 genes revealed an enrichment for YAP/TAZ-regulated genes. e) Canonical YAP/TAZ targets were
upregulated in C2C12 cells by BMP-2 and antagonized by Blebb. f) Hierarchical clustering analysis of the YAP targets identified from genes in (b).
Cells were then cultured for 1 day in the absence of BMP-2, af-
ter which luciferase reporter and ALP activity assays were per-
formed. Luciferase activity, which was low when pretreatment
only lasted 30 min, increased gradually until a pretreatment
length of 1 day, at which point luciferase activity became satu-
rated (Figure 5h). ALP activity followed a similar pattern (Fig-
ure 5i). Thus, higher-level gene activation caused by Smad com-
plexes in early signaling events only results in higher ALP activity
after the application of mechanical cues. When cell proliferation
is inhibited by mitomycin C, 1 day of BMP-2 stimulation is suffi-
cient to activate osteogenic differentiation in C2C12 cells. More-
over, luciferase activity and ALP activity did not decrease when
pretreated cells were kept on antifouling TCPS for an additional
day without BMP-2 stimulation before being transferred onto ad-
hesive TCPS (Figure 5h,i). These results 1) highlight the role of
mechanotransduction in BMP-2-induced osteogenic differentia-
tion, and 2) prove that C2C12 osteogenic commitment can be
initiated in a step-wise process via independent pulsed BMP-
2 stimulation and mechanical cues. In other words, cells can
“remember” BMP-2 stimulation history via Smad complex gene
targeting. Osteogenic differentiation is subsequently activated
via nuclear YAP/TAZ translocation as a function of cytoskeletal
tension.
Human MSCs are a useful model for mechanosensitive stem
cell differentiation. Similar to our findings in C2C12 cells, we
observed osteogenic differentiation of MSCs in response to
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Figure 5. Synergy between BMP-2 signaling and mechanotransduction. a) Antifouling coating scheme on TCPS. b) Scheme of the experimental setup.
C2C12s were cultured on antifouling TCPS (green) with BMP-2 stimulation (blue) for 30 min to 3 days. BMP-2 was removed (red) and C2C12s were
maintained in culture on antifouling TCPS for 1 day. C2C12s were subsequently transferred onto adhesive TCPS (yellow) for 1–3 days. c) C2C12 BRE-Luc
cell luciferase activity when cultured on antifouling or adhesive TCPS for 1 day; n = 3, two technical replicates. d) C2C12 BRE-Luc cell luciferase activity
when pretreated with BMP-2 on antifouling TCPS for 1 day and then transferred onto antifouling or adhesive TCPS in the presence (+) or absence (–) of
BMP-2; n= 3, two technical replicates. e) Representative immunofluorescence images of BMP-2-pretreated (1 day) C2C12 cells stained with DAPI (blue),
Alexa Fluor 488 phalloidin (green), and anti-YAP (red) after being transferred onto adhesive TCPS for 20 min or 24 h, and related nuclear-to-cytoplasmic
ratios of YAP; n = 20, Welch’s t-test. High-magnification images of anti-YAP are available in Figure S13, Supporting Information. f) Quantitative ALP
activity assay for C2C12 cells pretreated with BMP-2 on antifouling TCPS for 1 day and then transferred onto antifouling or adhesive TCPS in the presence
(+) or absence (–) of BMP-2; n = 3. g) Representative images of ALP staining for C2C12 cells pretreated with BMP-2 on antifouling TCPS for 1 day and
then transferred onto adhesive TCPS in the presence or absence of BMP-2. h) Luciferase activity of C2C12 BRE-Luc cells and i) ALP activity of C2C12
cells pretreated with BMP-2 on antifouling TCPS from 30 min to 3 days, and then transferred onto adhesive TCPS without BMP-2 for 1 day. For “1 d-1 d”
samples, cells were pretreated with BMP-2 on antifouling TCPS for 1 day, and then cultured for an additional day on antifouling TCPS without BMP-2,
before being transferred onto adhesive TCPS without BMP-2 for a final day; n = 4 for luciferase activity and n = 3 for ALP activity. The cell proliferation
was limited by mitomycin C. Data are analyzed by one-way ANOVA followed by post hoc Tukey’s multiple comparisons test (except in (e), Welch’s t-test).
stimulation with BMP-2 and mechanical cues (Figures S14–S16,
Supporting Information). As MSCs are widely used in regenera-
tive medicine and hold great therapeutic potential, these results
extend our findings to more translational conditions.
3. Discussion
BMPs are a potent class of growth factors that regulate the de-
velopment of many organ systems in the body and play an espe-
cially important role in osteogenesis. BMP therapies are becom-
ing promising alternatives to autografts, which are currently the
gold standard for chronic bone defects, but remain limited by low
availability as well as donor site pain and inflammation.[16,44] Dys-
regulation of BMP signaling has been shown to contribute to a
number of pathological processes, including cancer and ectopic
bone formation.[45,46] Thus, understanding how BMP-2 regulates
differentiation and manipulating BMP-2 signaling are both crit-
ically important for both clinical regenerative medicine and the
rational design of growth factor-doped biomaterials.
In this study, BMP-2-induced C2C12 osteogenesis was in-
vestigated from two complementary directions: 1) biochemical
pathways that have been shown to play a role in BMP-2 signal-
ing, and 2) mechanotransduction pathways that are influenced
by different matrix stiffness or the application of cytoskeletal
tension-modifying inhibitors. These synergistic modalities are
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Figure 6. Synergy between cytoskeletal tension (YAP/TAZ) and the BMP-2-Smad pathway. Left: No activated Smad signaling or osteogenic differentia-
tion is observed in the absence of BMP-2, even in the presence of stiff matrix. Right: The initiation of BMP-2-induced Smad signaling is independent
of cytoskeletal tension. Smad1/5/8 can be phosphorylated and form heteromeric complexes that translocate into the nucleus and bind to target genes.
However, osteogenic gene activation requires cytoskeletal tension-induced nuclear accumulation of YAP/TAZ. Thus, BMP-2 signaling responds to me-
chanical cues by sensing nucleocytoplasmic shuttling of YAP/TAZ.
summarized in Figure 6. By transiently downregulating and up-
regulating the expression of YAP and TAZ in C2C12s, we found
that they contribute to the crosstalk between BMP-2 signaling
and mechanotransduction pathways. Additionally, the shuttling
of YAP and TAZ from the cytoplasm to the nucleus is indepen-
dent of BMP-2 signaling, but this translocation enhances BMP-2-
induced differentiation. In parallel, the initiation of Smad signal-
ing is independent of mechanical cues. Crosstalk between these
two signaling pathways synergistically enhances osteogenic gene
expression.
The crosstalk between BMP-2 signaling and mechanotrans-
duction pathways is likely due to binding between Smad het-
eromeric complexes and YAP/TAZ, possibly via phosphorylated
Smad1,[47,48] as well as the assistance of other YAP/TAZ-binding
transcription factors. It has been suggested that TAZ coactivates
RUNX2-dependent gene transcription, driving cells towards os-
teogenic differentiation under BMP-2 stimulation.[49] In other
studies focusing on TGF-𝛽 signaling, the osteogenic gene activa-
tion is suggested to be coassociated with TEAD[50] and OCT4.[51]
Thus, gene activation is likely the result of synergistic coopera-
tion between multiple transcription factors regulated by diverse
stimuli, as indicated by RNA-seq analysis.
In 3D systems, YAP/TAZmay be regulated bymechanical cues
in a different way than on 2D surfaces, likely due to spatial limita-
tions on cytoskeletal assembly.[52] For example, YAP/TAZ nuclear
localization has been shown to be higher in cells encapsulated
in soft hydrogels than in stiff ones.[53,54] Cells sense mechanical
cues in both 2D and 3D conditions via the same mechanotrans-
duction pathways. Thus, the key step in mechanotransduction
in both 2D and 3D conditions is the generation of intracellular
cytoskeletal tension. This tension is capable of inducing down-
stream YAP/TAZ nuclear localization and further crosstalk with
BMP-2 signaling pathways. In this work, we chose to focus on the
intrinsic myosin-based cytoskeletal tension generated on simple
2D material models, but it is reasonable to speculate that these
same molecular mechanisms can be extended to 3D systems.
Smad signaling can be initiated by pulse BMP-2 stimulation,
which becomes saturated within 1 day. Interestingly, Smad
complexes can continue binding to and activating target genes
regardless of external mechanical cues after the removal of the
BMP-2 stimulus. This maintenance enables Smad-activated
cells to either keep their phenotype without applying further
mechanical cues or differentiate to osteoblasts by applying later
mechanical cues. The differentiation process is therefore pro-
grammable, a fact that can be leveraged in the future to control
cells and growth factors in biomedical engineering. Please note
the cell proliferation can dilute the concentration of targeted
Smad complexes on genes. We only focused on the molecular
mechanism and used mitomycin C to limit this dilution. For
practical applications, we would suggest to initially treat cells
with relatively high concentration of BMP-2 for about 1 day
and to keep the BMP-2 concentration in relatively low level to
continuously stimulate the proliferated cells. Furthermore, this
sequential activation of differentiation programming may play
a major role in cellular differentiation in vivo, where migrating
stem cells are exposed to diverse and dynamic mechanical and
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biochemical environments on their journey from the stem cell
niche to their ultimate differentiation site.
In addition to canonical Smad signaling, BMP-2 also induces
noncanonical pathways by activating MAPK cascades through
Smad in a transcription-independent fashion.[55,56] However, the
molecular basis for the activation and signal transduction of non-
canonical pathways is still not fully understood.
YAP/TAZmay not be the only crosstalk point betweenmechan-
otransduction pathways and BMP-2 signaling. Integrins, which
have been shown to colocalize with BMP-2 receptors,[57] may
play a role in integrating mechanical signals with BMP-2 sig-
naling. Indeed, BMP-2 stimulation has been shown to up-
regulate the expression of multiple types of 𝛼v𝛽- integrins
in human osteoblasts.[57] In addition, 𝛼v𝛽3 integrin mediates
BMP-2-induced Smad signaling through the Cdc42-Src-FAK-
ILK cascade.[21] Moreover, other cell membrane receptors like
N-cadherin[58] and FGF receptor[59] have been found to modu-
late BMP-2. ROCK activity and RhoA/ROCK-mediated cytoskele-
tal tension also regulate BMP-induced Smad signaling and os-
teogenic differentiation in human MSCs.[15] Although it has
been demonstrated that mechanical cues affect Smad signaling
through the various signaling pathways described above, here we
demonstrate for the first time that cytoskeletal tension-mediated
nuclear accumulation of YAP/TAZ is critical for BMP-2 signaling
and subsequent osteogenic differentiation.
4. Conclusion
Overall, we used a carefully selected model cell line to study
the crosstalk between BMP-2 signaling and mechanotransduc-
tion pathways to understand how these two disparate modalities
can synergize to mediate osteogenic differentiation at a molecu-
lar level. We identified YAP/TAZ as a primary crosstalk junction
and demonstrated the integration of these two distinct pathways
for altered gene transcription. In addition, Smad complexes, the
transcription factors involved heavily in BMP-2 signaling, were
found to maintain BMP-2 activity and remain bound to target
genes after BMP-2 withdrawal. This observation was then lever-
aged to dictate programmable BMP-2 stimulation and mechan-
ical cues for on-demand cell fate determination. Investigations
into the role of mechanotransduction in BMP signaling may
identify important mechanisms linking chemical cues from the
extracellular environment to physical cues from the ECM during
cell differentiation and tissue development. Understanding this
link will allow for the guided design of new biomaterials for re-
generative therapies, as well as provide critical information on the
use of BMP as a therapeutic tool for enhancing clinical bone re-
pair success. Ultimately, future tissue engineering strategies for
bone repair must take both biochemical and mechanobiological
phenomena into account.
5. Experimental Section
PEG Hydrogels Fabrication and Mechanical Characterization: PEG hy-
drogel stiffness was controlled by varying poly(ethylene glycol)-diacrylate
(PEG-DA) macromer with Mn 700 (455008 Sigma-Aldrich) concentration
in water. Specifically, 80, 100, 200, and 400 mg mL–1 concentrations were
utilized. The adhesive peptide cyclo(Arg-Gly-Asp-D-Phe-Cys) (c(RGDfC),
PCI-3686-PI, Peptides International) was added to the PEG-DA solution
at a constant concentration of 100 × 10−6 m. The photoinitiator Irgacure
2959 (410896, Sigma-Aldrich) was then mixed into the solution to achieve
an initiator-to-acrylate ratio of 1:100. The gelation solution was pipet-
ted onto glass coverslips modified with 3-(trimethoxysilyl)propyl acrylate
(475149, Sigma-Aldrich) and covered with quartz slides modified with
1H,1H,2H,2H-perfluorodecyltrichlorosilane (L1658403, Alfa Aesar). Poly-
merization was initiated via 365 nm UV irradiation. Fabricated hydrogels
were equilibrated in phosphate-buffered saline (PBS) buffer before use.
For cell experiments, the c(RGDfC) peptide was utilized as an adhesive
ligand. RGD peptide concentration was kept constant at 100 × 10−6 m,
comparable to previous biological studies,[60] and was sufficient to allow
cells to adhere, but not induce spatial sensing-induced cell adhesion.[61]
Mechanical properties of the hydrogels were measured with a rotational
rheometer (Kinexus Pro, Malvern) in a humidity chamber at a constant
shear rate of 1 Hz.
Cell Culture and Inhibitor Treatment: Mouse C2C12 myoblasts (ATCC
CRL-1772) were cultured as subconfluent monolayers in growth me-
dia, consisting of 𝛼-MEM (A1049001, Gibco) supplemented with 10%
fetal bovine serum (S0115, Biochrom) and 1% penicillin/streptomycin
(15140122, Gibco) at 37 °C and 5% CO2.
Cells were serum-starved in serum-free growth media for 3–4 h before
stimulation with 20 × 10−9 m recombinant human BMP-2 (rhBMP-2, Mor-
phoplant GmbH) in growth media. For cells stimulated with BMP-2 on
antifouling surfaces, BMP-2 was removed before cell transfer. Since cells
could not adhere to the antifouling surface, their removal was possible
with gentle pipetting. For this, media and cells were gently collected, cen-
trifuged, and washed with PBS at least three times to remove residual ex-
ogenous BMP-2 before seeding to new antifouling or cell adhesive TCPS.
For inhibitor studies, 20× 10−6 m (–)blebbistatin (Blebb, B0560, Sigma-
Aldrich) or 1× 10−9 m calyculin A (Calyc, C5552, Sigma-Aldrich) was added
to cell culture media. To prevent cell proliferation during Smad complex
analysis post-BMP-2 removal, cells were treated with 10 µg mL–1 mito-
mycin C for 2 h before use.
ALP Assay: The SensoLyte pNPP alkaline phosphatase assay kit Colori-
metric (AnaSpec) was used according to the manufacturer’s instructions.
Cell numbers were counted prior to lysis. Final values were measured at
a wavelength of 405 nm with a Tecan Infinite M200 Plate Reader. ALP
staining was performed with Leukocyte Alkaline Phosphatase kit based on
Naphthol AS-BI and fast blue BB salt (86C, Sigma-Aldrich) according to
manufacturer’s instructions.
Protein Isolation and Western Blot Analysis: Cells were lysed in RIPA
buffer (89900, Thermo Fisher Scientific) freshly supplemented with pro-
tease and phosphatase inhibitor cocktails (78442, Thermo Fisher Scien-
tific) on ice and then centrifuged at 14 000 × g for 15 min at 4 °C. Lysates
were collected and stored at –20 °C. After BCA assays to determine con-
centration, protein extracts were separated via SDS-PAGE and transferred
to a nitrocellulose membrane. After blocking with 5% BSA in TBST for 1 h,
membranes were incubated overnight with diluted primary antibodies in
5% BSA in TBST at 4 °C followed by secondary HRP-linked antibodies at
room temperature for 2 h. Chemiluminescence via Amersham ECL Prime
Western Blotting Detection Reagent (GE Healthcare) was detected with a
Fujifilm LAS-3000 Imager. ImageJ was used for band quantification.
For the Western blot analysis of pSmad1/5/8, more than 10 k cells were
seeded on substrates in serum-free growth media for 3 h before stimula-
tion with 20 × 10−9 m BMP-2 for 1 more hour. If required, 20 × 10−6 m
Blebb or 1× 10−9 m Calyc was added during the whole 4 h. For theWestern
blot analysis of YAP/TAZ, more than 10 k cells were treated as described
below (Section RNA Interference and Plasmid Transfection).
Primary antibodies and corresponding concentrations used in this
study were rabbit anti-pSmad1/5/8(9) (1:1000) (13820, Cell Signaling
Technology), rabbit anti-YAP (1:1000) (4912, Cell Signaling Technology),
mouse anti-TAZ (1:1000) (560235, BD Pharmingen), mouse anti-𝛽-actin
(1:2000) (A1978, Sigma-Aldrich), and mouse anti-FLAG (1:1000) (F1804,
Sigma-Aldrich). Secondary antibodies were HRP-linked anti-rabbit IgG
(1:2000) (7074, Cell Signaling Technology) and HRP-linked anti-mouse
IgG (1:2000) (7076, Cell Signaling Technology). PageRuler Plus Prestained
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Protein Ladder, 10–250 kDa, served as a molecular weight marker (26619,
Thermo Fisher Scientific).
Luciferase Assay: Luciferase assays were performed using the Lu-
ciferase Assay System (E1500, Promega) according to the manufacturer’s
instructions. C2C12 BRE-Luc cells stably transfected with pGL3(BRE)-
luciferase reporter construct have been previously described.[32] Cell num-
bers were counted prior to lysis. Chemiluminescence was detected with a
Tecan Infinite M200 Plate Reader and normalized to cell counts.
Immunofluorescence Staining and Microscopy: Cells were washed once
with cell culture media and twice with PBS before fixation with 4%
paraformaldehyde at room temperature for 15 min. Samples were then
washed thrice with ice cold PBS. Cells were permeabilized with 0.25% v/v
Triton X-100 in PBS for 10 min at room temperature, then washed thrice
with PBS. Nonspecific antibody binding was blocked by incubating sam-
ples with 1% w/v bovine serum albumin (BSA) in PBST (0.1% v/v Triton
X-100 in PBS) at room temperature for 45min. Next, samples were washed
briefly with PBST and incubated with primary antibodies for 60 min at
room temperature. Following primary antibody incubation, samples were
washed twice with PBST and thrice with PBS. Samples were then incubated
with secondary antibodies and Alexa Fluor 488 phalloidin for 60 min at
room temperature, followed by washing twice with PBST and thrice with
PBS. Finally, samples were placed on microscope slides in Fluoromount-
G with DAPI (00-4959-52, eBioscience) mounting media. Immunofluores-
cence images were acquired on an Axiovert 200MMicroscope (Carl Zeiss).
Primary antibodies and corresponding concentrations used were rab-
bit anti-pSmad1/5/8(9) (1:200) (13820, Cell Signaling Technology), rab-
bit anti-YAP (1:100) (4912, Cell Signaling Technology), mouse anti-TAZ
(1:100) (560235, BD Pharmingen), rabbit anti-Osterix (1:100) (ab22552,
Abcam), and mouse anti-myosin heavy chain (1:10) (MF20, Develop-
mental Studies Hybridoma Bank, University of Iowa). Secondary antibod-
ies used were Alexa Fluor 568-linked anti-rabbit IgG (1:1000) (A11011,
Thermo Fisher Scientific), Alexa Fluor 647-linked anti-mouse IgG (1:1000)
(A21235, Thermo Fisher Scientific), and Alexa Fluor 488-linked anti-mouse
IgG (1:1000) (A11029, Thermo Fisher Scientific).
RNA Extraction and qRT-PCR: Total RNA was isolated using TRIzol
reagent (15596026, Invitrogen) according to the manufacturer’s instruc-
tions. Collected RNA was converted to cDNA using a high-capacity cDNA
reverse transcription kit (4368814, Applied Biosystems) along with an iCy-
cler thermal cycler gradient (Bio-Rad) according to the manufacturer’s in-
structions. Gene expression profiles were determined for RUNX2, ALP,
and OPN with glyceraldehyde 3-phosphate dehydrogenase used as a
housekeeping gene. qRT-PCR was carried out on a 7500 Real-Time PCR
System (Applied Biosystems). cDNAwas amplified with the following con-
ditions: 1 cycle at 50 °C for 2min and 95 °C for 2min, then 40 cycles at 95 °C
for 15 s and 60 °C for 1min. Amplification wasmonitored with SYBRGreen
(4309155, Applied Biosystems). Data were then normalized to the house-
keeping gene as an index of cDNA content after reverse transcription and
further normalized to the group on TCPS at day 1. Primer sequences[62]
are listed in the Table S1, Supporting Information.
RNA-Seq: Total RNA from C2C12 cells was extracted with a Quick-
RNA miniprep kit from Zymo Research (R1055) following manufacturer’s
instructions. RNA concentration was assessed via NanoDrop and then
stored at –80 °C.
For RNA-Seq experiments, library preparation was performed with the
TruSeq RNA Sample Prep Kits v2 (Illumina) following manufacturer’s in-
struction. RNA-Seq libraries were then run on the Agilent 2100 Bioanalyzer
(Agilent high-sensitivity DNA chip) for quantification and quality control
and then sequenced on NovaSeq 6000 (Illumina).
RNA Interference: To knock down endogenous YAP and TAZ levels,
C2C12 cells were transfected with siRNAs against YAP (TriFECTa DsiRNA
Kit, design ID, mm.Ri.Yap1.13, Integrated DNA Technologies, Inc.) or TAZ
(Stealth siRNAs MSS227747, MSS227748, MSS227749, Thermo Fisher
Scientific) using Lipofectamine 2000 (11668027, Thermo Fisher Scientific)
according to the manufacturer’s instructions. To analyze resulting protein
expression levels, cells were lysed for Western blot analysis at indicated
time points after transfection.
Cells were seeded in antibiotic-free growthmedia for 24 h prior to trans-
fection. Transfection solution was prepared as follows: 1 mgmL–1 Lipofec-
tamine 2000was diluted to 30 µgmL–1 inOpti-MEMmedia (31985, Gibco)
and mixed for 15 min, while 20 × 10−6 m solutions of each siRNA were di-
luted 20× to 1 × 10−6 m in a separate aliquot of Opti-MEM media. The
two solutions were then mixed at a 1:1 by volume for another 15 min at
room temperature. Afterwards, the final mixture was added into cell cul-
ture medium without antibiotics to achieve a final concentration of 100 ×
10−9 m for each siRNA in 3 µg mL–1 Lipofectamine 2000. Cells were then
incubated with siRNA for 24 h at 37 °C with 5% CO2. Cells treated with
Lipofectamine 2000 alone were used as a negative control group.
Plasmid Transfection: p2xFLAGhYAP1 and pEGFP-C3-hYAP1 plasmids
were provided by Marius Sudol (17791 and 17843, Addgene);[63,64]
pEF-TAZ-N-Flag plasmids were provided by Michael Yaffe (19025,
Addgene).[65] Plasmids were isolated and purified with a Qiagen Plasmid
Plus Midi Kit (12943, Qiagen) and were stored at –80 °C.
Cells were seeded in antibiotic-free growthmedia for 24 h prior to trans-
fection. Transfection solution was prepared as follows: 1 mgmL–1 Lipofec-
tamine 2000was diluted to 60 µgmL–1 inOpti-MEMmedia (31985, Gibco)
and mixed for 15 min, while 200 ng µL–1 solutions of plasmid were diluted
10× to 20 ng µL–1 in a separate aliquot of Opti-MEM media. The two so-
lutions were then mixed at a 1:1 by volume for another 15 min at room
temperature. Afterwards, the final mixture was added into cell culture me-
dia without antibiotics to achieve a final concentration of 1 ng µL–1 for each
plasmid in 3 µg mL–1 Lipofectamine 2000. Cells were then incubated with
plasmid for 24 h at 37 °C with 5% CO2. Cells treated with Lipofectamine
2000 alone were used as a negative control group.
Statistics: Statistical analysis was performed in GraphPad Prism 7.
One-way ANOVA followed by post hoc Tukey’s multiple comparisons test
or Welch’s t-test were carried out as described in figure captions. All re-
sults are displayed as mean ± standard deviation, *p < 0.05, **p < 0.01,
***p < 0.001, and ****p < 0.0001. Significance is indicated with by
*(p < 0.05).
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